Globus Medical reports record Q4 sales $823M (+25% YoY); FY2026 guidance $3.18-3.22B

GLOBUS MEDICAL INC

2025-FY EPS reported $3.92 revenue$2,938,931,000

Preliminary Q4 2025 sales ~$823.2M, +25.2% YoY; full year sales ~$2.936B, +16.5% YoY.
Base business (ex-Nevro) Q4 revenue $723.3M, +10.0% YoY, led by US Spine.
Enabling Technologies delivered best quarterly revenue performance to date.
FY2026 revenue guidance $3.18B-$3.22B; non-GAAP EPS guidance $4.30-$4.40.
Final Q4/FY2025 results expected on February 24, 2026 after market close.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.